These observations were supported by animal studies showing that cerebral ischemia leads to an increase of matrix-metalloproteinase (MMP) activity, especially of MMP-9 which follows the same time course as BBB disruption after experimental stroke and that both are aggravated by treatment with rt-PA [4] and correlate with HT [5]. This evidence concerns the gene MMP9 and stroke disorder.